Check out the companies making headlines before the bell:
Pfizer – The drugmaker is buying Array Biopharma for $48 per share in cash, or $11.4 billion, including debt. That’s a 62% premium over Array’s Friday close. Array specializes in treatments for diseases where there is a large unmet need, as well as cancer drugs.
Boeing – Boeing CEO Dennis Muilenburg told reporters at the Paris Air Show that it will take time to win back the confidence of its customers following the two fatal